期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
水稻品种抗稻瘟病菌集团菌株频率在抗病鉴定中的应用研究 被引量:4
1
作者 黄瑞荣 何月秋 曾小萍 《江西农业学报》 CAS 1992年第1期51-56,共6页
本研究以水稻品种抗稻瘟病菌集团菌株频率和自然病圃中病情关系,获得抗病频率(Υ%)与混合菌株接种的穗期病情的线性模型=4.3635-0.0452Υ±O.4238,与自然病圃中品种的病情的线性模型=4.2442-0.0415Υ±0.4955。两模型回测,在概... 本研究以水稻品种抗稻瘟病菌集团菌株频率和自然病圃中病情关系,获得抗病频率(Υ%)与混合菌株接种的穗期病情的线性模型=4.3635-0.0452Υ±O.4238,与自然病圃中品种的病情的线性模型=4.2442-0.0415Υ±0.4955。两模型回测,在概率P_(0.05)下准确率均为100%,并以后一模型为依据,在病菌来源地的萍乡市和乐安县布局品种,得到证实。 展开更多
关键词 集团菌株 抗病频率 稻瘟病菌 水稻 品种 抗病
下载PDF
转GO基因水稻杂交后代稻瘟病抗谱分析 被引量:2
2
作者 谢戎 刘成元 +2 位作者 李永洪 向箭宇 邵继荣 《西南农业学报》 CSCD 北大核心 2015年第5期1869-1873,共5页
转基因技术为水稻抗稻瘟病育种提供了新的技术手段。以转GO基因蜀恢162阳性单株为母本,与恢复系乐恢188、晋恢21、明恢63及R473分别复交,对20个农艺性状优良的复交后代株系进行抗谱测定。结果表明,HR320及HR332两个转GO基因后代株系总... 转基因技术为水稻抗稻瘟病育种提供了新的技术手段。以转GO基因蜀恢162阳性单株为母本,与恢复系乐恢188、晋恢21、明恢63及R473分别复交,对20个农艺性状优良的复交后代株系进行抗谱测定。结果表明,HR320及HR332两个转GO基因后代株系总群抗病频率分别为86.3%和84.3%,与Tetep的88.2%相当。Tetep不抗ZA群生理小种,但HR320对ZA15,HR332对ZA11及ZA15的抗病频率均为100%。多数稻瘟病抗源材料的总群抗病频率及小种抗病频率都高于转GO基因杂交后代。HR320及HR332在稻瘟病抗病育种中有应用潜力。 展开更多
关键词 转基因水稻 葡萄糖氧化酶基因 稻瘟病 抗病频率 复合杂交
下载PDF
Effectiveness of infliximab after adalimumab failure in Crohn's disease 被引量:1
3
作者 María Chaparro Montserrat Andreu +8 位作者 Manuel Barreiro-de Acosta Esther García-Planella Elena Ricart Eugeni Domènech María Esteve Olga Merino Pilar Nos Mireia Pealva Javier P Gisbert 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第37期5219-5224,共6页
AIM:To evaluate the effectiveness of infliximab as a second-line therapy in Crohn's disease patients after adalimumab failure. METHODS:A historical cohort study in a community-based gastroenterology practice evalu... AIM:To evaluate the effectiveness of infliximab as a second-line therapy in Crohn's disease patients after adalimumab failure. METHODS:A historical cohort study in a community-based gastroenterology practice evaluated Crohn's disease patients treated with infliximab (induction plus maintenance) after adalimumab failure. Patients were identified using a large Spanish database (ENEIDA). RESULTS:We included 15 Crohn's disease patients who received infliximab after adalimumab failure. Five patients discontinued adalimumab due to loss of response, 3 due to adverse events and 7 due to partial response. After infliximab therapy was started, all patients who had interrupted adalimumab due to loss of efficacy regained response. All patients who discontinued adalimumab due to adverse events responded to infliximab and maintained this response; one of these patients had an uneventful course on infliximab, but 2 developed adverse events. None of the 7 patients who interrupted adalimumab due to partial response reached remission with infliximab. CONCLUSION:Switching from adalimumab to infliximab may be useful in patients who develop adverse effects or loss of response, however, the benefit of infliximab in primary nonresponders was not established. 展开更多
关键词 ADALIMUMAB BIOLOGICS Crohn's disease In-fliximab SWITCH
下载PDF
Building a Resilient Wheat Seed System to Resist Rust Risks in Ethiopia
4
作者 Abebe A. Gizaw Karta K. Kalsa 《Journal of Life Sciences》 2017年第1期19-29,共11页
This study is a review of existing reports and summary of some field experiences aiming at building of a resilient wheat seed system to resist rust risks in Ethiopia. Practical gaps in the wheat seed system were ident... This study is a review of existing reports and summary of some field experiences aiming at building of a resilient wheat seed system to resist rust risks in Ethiopia. Practical gaps in the wheat seed system were identified with regard to understanding of seed system factors that build, or undermine resilience to rust risks. The study has recognized that the formal seed multiplication schemes are too slow to respond to the ever increasing frequencies of wheat rust outbreaks. Therefore, it is indicated that new approaches such as pre-release and farmer based seed multiplication schemes are helpful in insuring availability of seed of rust resistant wheat varieties to the small farmers. 展开更多
关键词 WHEAT seed system RESILIENCE rust.
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部